2013-01-02 15:28:49 -

BAGSVAERD, DENMARK -- (Marketwire) -- 01/02/13 -- In continuation of the company's
announcements dated 9 August 2012 and 9 November 2012 concerning planned
share repurchase programmes, and pursuant to Section 204.25 of the New York
Stock Exchange Listed Company Manual, this is to report that Novo Nordisk
A/S (NYSE: NVO) and its wholly-owned affiliates on 31 December 2012 owned
17,416,676 of its own B shares of DKK 1, corresponding to a total nominal
value of DKK 17,416,676 or 3.1% of the total share capital.





Company announcement No 02 / 2013:
hugin.info/2013/R/1667832/541468.pdf : hugin.info/2013/R/1667832/541468.pdf



This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:



(i) the releases contained herein are protected by copyright and
other applicable laws; and



(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.



Source: Novo Nordisk A/S via Thomson Reuters ONE



[HUG#1667832]




Further information
Media:
Anne Margrethe Hauge
+45 4442 3450
Email Contact : www2.marketwire.com/mw/emailprcntct?id=7FB147AD259AD981

Ken Inchausti (US)
+1 609 514 8316
Email Contact : www2.marketwire.com/mw/emailprcntct?id=849279E7175060F3

Investors:
Kasper Roseeuw Poulsen
+45 4442 4303
Email Contact : www2.marketwire.com/mw/emailprcntct?id=3B7875E9DF0E97FC

Frank Daniel Mersebach
+45 4442 0604
Email Contact : www2.marketwire.com/mw/emailprcntct?id=F5DD0CD318526D05

Lars Borup Jacobsen
+45 3075 3479
Email Contact : www2.marketwire.com/mw/emailprcntct?id=215F75A6CDF12A41

Jannick Lindegaard (US)
+1 609 786 4575
Email Contact : www2.marketwire.com/mw/emailprcntct?id=E54BD7F5D856F911